PHARMAVOICE RECOGNIZES FRANK X. POWERS IN ENTREPRENEUR FEATURE

ELEVATE CO-FOUNDER TALKS ABOUT CREATION OF THE AGENCY

The June 2019 issue of PharmaVOICE has a featured article about entrepreneurs and their passion to improve the lives of patients. Elevate founding partner Frank X. Powers was highlighted, where he discussed the origins of Elevate, born from the marketplace need he and his partner recognized—a need that was worth taking the risk.

Powers said, “There were whole segments of our market that needed more attention from experienced talent. Elevate was created to fill that void.”

Powers and his partner Lorna Weir saw what was going on in their business and understood that shifting to a new business model, with a new organization, was the next natural step. The mission was to create a company that raised the standards of service and creative that clients have access to. Both of Frank’s parents are successful entrepreneurs, so starting a company from the ground up is in his DNA. But that also means he was more familiar with the risks involved.

On the official launch of Elevate, Frank says “I was at our conference table with colleagues thinking this is the end of a long process, and also just the beginning.”

The success Elevate has seen since each year since has been even more satisfying for Frank and Lorna, neither of whom took a salary until the business could comfortably handle it. Of all Frank’s amazing accomplishments, included being a two-time member of the PharmaVOICE 100, launching Elevate ranks first for him.

Visit PharmaVOICE to read the entire article here: https://www.pharmavoice.com/digital-edition/june-2019/#56 

ABOUT PHARMAVOICE:
Published monthly, with the combined July/August PharmaVOICE 100 and November/December Year in Preview issues, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of the executives who are shaping the direction of the dynamic and multifaceted life-sciences industry. PharmaVOICE reaches more than 41,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE’s unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships. PharmaVOICE’s multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics to a wide range of life-science sectors.